Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment

Takanori Mizoguchi,1 Mineo Ozaki,2 Nobuchika Ogino3 1Mizoguchi Eye Clinic, Ophthalmology, Sasebo, Japan; 2Ozaki Eye Hospital, Ophthalmology, Miyazaki, Japan; 3Nishigaki Eye Clinic, Ophthalmology, Nagoya, Japan Purpose: To evaluate the efficacy and safety of 0.05% epinastine and 0.1% olopatadine ey...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Mizoguchi T, Ozaki M, Ogino N
Format: article
Langue:EN
Publié: Dove Medical Press 2017
Sujets:
Accès en ligne:https://doaj.org/article/bbb1fa0597144a6599e344fca39bab0a
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!